| Meldepflichtige Erreger |
|
|
Astrovirus
|
|
| Candida auris |
- Swissnoso. Empfehlungen zur Infektionsprävention und -kontrolle bei Candida auris 2022;Version 1.0
- Pacilli M, Kerins JL, Clegg WJ, Walblay KA, Adil H, Kemble SK, Xydis S, McPherson TD, Lin MY, Hayden MK, Froilan MC, Soda E, Tang AS, Valley A, Forsberg K, Gable P, Moulton-Meissner H, Sexton DJ, Jacobs Slifka KM, Vallabhaneni S, Walters MS, Black SR. Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility. Clin Infect Dis 2020;71(11):e718-e725
|
|
Clostridioides difficile
|
- Tschudin-Sutter S, Kuijper EJ, Durovic A, Vehreschild MJGT, Barbut F, Eckert C, Fitzpatrick F, Hell M, Norèn T, O'Driscoll J, Coia J, Gastmeier P, von Müller L, Wilcox MH, Widmer AF; Committee. Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clin Microbiol Infect 2018 (10):1051-1054
- Widmer AF, Frei R, Erb S, Stranden A, Kuijper EJ, Knetsch CW, Tschudin-Sutter S. Transmissibility of Clostridium difficile Without Contact Isolation: Results From a Prospective Observational Study With 451 Patients. Clin Infect Dis 2017;64(4):393-400
|
| Corynebacterium diphtheriae |
|
|
ESBL E. coli
|
- Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S. Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review. Clin Infect Dis 2017;65(2):342-347
- Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis 2012;55(11):1505-11
- Tschudin-Sutter S, Frei R, Schwahn F, Tomic M, Conzelmann M, Stranden A, Widmer AF. Prospective Validation of Cessation of Contact Precautions for Extended-Spectrum β-Lactamase-Producing Escherichia coli(1). Emerg Infect Dis 2016;22(6):1094-7
|
| Humanes Metapneumovirus |
|
| Masern |
|
| Middle East Respiratory Syndrome Coronavirus (MERS-CoV) |
|
| Mpox |
|
| Multiresistente Gramnegative Bakterien |
- Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B; European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20 Suppl 1:1-55
|
| Mycobacterium tuberculosis |
|
| Norovirus |
- Brown LK, Ruis C, Clark I, Roy S, Brown JR, Albuquerque AS, Patel SY, Miller J, Karim MY, Dervisevic S, Moore J, Williams CA, Cudini J, Moreira F, Neild P, Seneviratne SL, Workman S, Toumpanakis C, Atkinson C, Burns SO, Breuer J, Lowe DM. A comprehensive characterization of chronic norovirus infection in immunodeficient hosts. J Allergy Clin Immunol 2019;144(5):1450-1453
- Green KY. Norovirus infection in immunocompromised hosts. Clin Microbiol Infect 2014;20(8):717-23
|
| Neisseria meningitidis |
|
| Plesiomonas shigelloides |
|
| Prionen-assoziierte Erkrankungen |
|
| Respiratory Syncytial Virus |
|
| Sapovirus |
|
| Vancomycin-resistente Enterokokken |
|
| Vibrio cholerae |
|
| Vogelgrippe |
|